With longer treatment duration, the BCR::ABL1 transcript quantity decreases gradually supporting the biological hypothesis of non-transcript producing quiescent CML cells also in pediatric CML patients43,44. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.